Understanding what people value about vaccines to improve vaccination policy and uptake
Official title: Additional Studies MeasuringPreferences and Values for Prevention of RSV and other Vaccine-Preventable Diseases\"
Funded at University of Michigan at Ann Arbor · NIH-11621293 · Data updated 2026-11-12
A payer/policy-focused project uses surveys to learn what matters to people about vaccines so decisions can help more people get vaccinated.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $240,000 |
| NIH project number | 6U01IP001198-03M002 |
| Project ID | NIH-11621293 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable here since the work informs policy and does not enroll patients in a clinical study.
✕Less likely to help
Direct patient participation is not part of a clinical trial; individuals may benefit indirectly through improved policies.
What this research studies
This project partners with CDC experts to design and run several economic surveys that explore why people choose to vaccinate or not. The results will help shape vaccination policies and interventions aimed at increasing vaccine uptake. The work focuses on translating survey findings into practical insights for policymakers, providers, and communities. The study aims to provide timely data to support Healthy People 2030 vaccination objectives.
Why it matters
Potential benefit: Better-informed vaccine policies and outreach could help increase vaccination rates and protect more people from preventable diseases.
How similar studies have gone: Previous vaccine-policy surveys have successfully informed decisions, but this project uses multiple innovative economic survey methods to enhance impact.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Prosser, Lisa a. — University of Michigan at Ann Arbor
- Study coordinator: Prosser, Lisa a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.